| Dr Noah M Bray, DPT | |
|
200 South Hubbard St, Plains, MT 59859 | |
| (406) 826-4384 | |
| Not Available |
| Full Name | Dr Noah M Bray |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 11 Years |
| Location | 200 South Hubbard St, Plains, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710324306 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-3187 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Axis Physical Therapy | 5597700823 | 6 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
Physicians use standard disease classifications based on symptoms or location in the body to help make diagnoses. These classifications, called nosologies, can help doctors understand which diseases are closely related, and thus may be caused by the same underlying issues or respond to the same treatments.
Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 6 days ago
| Provider Name | Axis Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912063512 PECOS PAC ID: 5597700823 Enrollment ID: O20050627000829 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
Physicians use standard disease classifications based on symptoms or location in the body to help make diagnoses. These classifications, called nosologies, can help doctors understand which diseases are closely related, and thus may be caused by the same underlying issues or respond to the same treatments.
Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 6 days ago
| Provider Name | Plains Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235389909 PECOS PAC ID: 8022178292 Enrollment ID: O20081118000220 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
Physicians use standard disease classifications based on symptoms or location in the body to help make diagnoses. These classifications, called nosologies, can help doctors understand which diseases are closely related, and thus may be caused by the same underlying issues or respond to the same treatments.
Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Noah M Bray, DPT 838 Stoddard St, Missoula, MT 59802-2406 Ph: (406) 396-9249 | Dr Noah M Bray, DPT 200 South Hubbard St, Plains, MT 59859 Ph: (406) 826-4384 |
News Archive
Those who faithfully brush their teeth each morning and night might feel as though they're doing enough to achieve a healthy smile. However, even people with good oral care habits may hear from their dentist or hygienist that they have signs of gingivitis, an early form of gum disease.
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
Physicians use standard disease classifications based on symptoms or location in the body to help make diagnoses. These classifications, called nosologies, can help doctors understand which diseases are closely related, and thus may be caused by the same underlying issues or respond to the same treatments.
Ultraviolet C light disinfection to clean unoccupied patient rooms significantly reduced C. difficile infections (CDI) in high-risk patients who later occupied those rooms, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
› Verified 6 days ago
Curt Hammill, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 Fax: 406-826-4384 | |
Emily Christine Herndon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Hubbard St, Plains, MT 59859 Phone: 406-531-5395 | |
Ross Eckstein, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Stuart Meints, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 | |
Mrs. Nicole Lynn Feliksa, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 12 Mt Highway 28, Plains, MT 59859 Phone: 406-826-4383 Fax: 406-826-4394 |